Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    1(33%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Not Applicable
    1
    33%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    N/ANon-phased studies
    1(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(1)
    Completed(1)
    Other(1)

    Detailed Status

    Completed1
    unknown1
    Recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    1
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A1 (100.0%)

    Trials by Status

    completed133%
    unknown133%
    recruiting133%

    Recent Activity

    1 active trials
    Showing 3 of 3
    recruiting

    FebriDx® Pediatric Validation Study

    NCT07211997
    completed

    FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test

    NCT02018198
    unknownnot_applicable

    Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study

    NCT05534555

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT07211997

    FebriDx® Pediatric Validation Study

    Recruiting
    NCT02018198

    FebriDx DISRUPT Acute Respiratory Infection Trial in Acute Respiratory Infection: An Evaluation of FebriDx® POC Test

    Completed
    NCT05534555Not Applicable

    Point of Care Testing Using FebriDx in Primary Care: a Mixed Methods Feasibility Study

    Unknown

    All 3 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    3